Efficacy and Safety of Lonigutamab in Subjects With Thyroid Eye Disease (TED)
Clinical trial NCT05683496 · COMPLETED
Trial details
- NCT number
- NCT05683496
- Sponsor
- ACELYRIN Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-14
- Primary completion
- 2025-05-26
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.